Nifty
:
22936.75
Sensex
:
74151.04
237.90 (1.05%)
905.01 (1.24%)
Nifty
Sensex
:
:
22936.75
74151.04
237.90 (1.05%)
905.01 (1.24%)

Indoco Remedies Ltd.

Pharmaceuticals & Drugs - Global

Rating :
49/99

BSE: 532612 | NSE: INDOCO

NSE BSE
209.50
29-Oct-2026
  • Open
  • High
  • Low
  • Previous Close
  •  214.25
  •  216
  •  208.2
  •  213.75
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  138127
  •  29136078.05
  •  288
  •  162.19

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,936.38
  • 61.87
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 2,870.06
  • 0.10%
  • 1.93

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 58.92%
  • 2.94%
  • 16.95%
  • FII
  • DII
  • Others
  • 1.64%
  • 16.44%
  • 3.11%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 5.55
  • 3.67
  • 0.51

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -1.18
  • -15.91
  • -10.31

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 24.38
  • 22.45
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.08
  • 2.96
  • 2.54

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 19.04
  • 19.17
  • 24.01

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 26
Sep 25
Var%
Jun 26
Jun 25
Var%
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Net Sales
520.17
484.67
7.32%
467.50
437.89
6.76%
475.61
390.21
21.89%
445.36
410.55
8.48%
Expenses
473.74
441.62
7.27%
426.48
420.36
1.46%
425.90
390.99
8.93%
413.85
398.52
3.85%
EBITDA
46.43
43.05
7.85%
41.02
17.53
134.00%
49.71
-0.78
-
31.51
12.03
161.93%
EBIDTM
8.93%
8.88%
8.77%
4.00%
10.45%
-0.20%
7.08%
2.93%
Other Income
1.97
0.76
159.21%
2.18
1.63
33.74%
-0.04
2.02
-
0.98
0.85
15.29%
Interest
26.91
24.56
9.57%
28.29
26.12
8.31%
45.92
17.98
155.39%
25.64
16.11
59.16%
Depreciation
34.44
32.25
6.79%
34.53
29.70
16.26%
32.49
28.78
12.89%
32.01
28.72
11.46%
PBT
24.19
-13.53
-
77.72
-36.66
-
-25.00
-45.52
-
-31.31
-30.96
-
Tax
4.72
-4.32
-
12.28
-0.31
-
-1.32
-4.18
-
-1.86
-2.56
-
PAT
19.47
-9.21
-
65.44
-36.35
-
-23.68
-41.34
-
-29.45
-28.40
-
PATM
3.74%
-1.90%
14.00%
-8.30%
-4.98%
-10.59%
-6.61%
-6.92%
EPS
1.99
-0.86
-
7.04
-3.88
-
-2.34
-4.38
-
-3.23
-2.86
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Net Sales
1,908.64
1,845.32
1,664.92
1,817.29
1,668.61
1,540.75
1,241.53
1,106.58
968.45
1,041.94
1,074.77
Net Sales Growth
10.75%
10.84%
-8.38%
8.91%
8.30%
24.10%
12.20%
14.26%
-7.05%
-3.05%
 
Cost Of Goods Sold
599.32
541.74
498.18
559.18
521.29
456.79
354.10
330.43
320.25
347.83
361.27
Gross Profit
1,309.32
1,303.58
1,166.73
1,258.10
1,147.32
1,083.97
887.42
776.15
648.19
694.11
713.49
GP Margin
68.60%
70.64%
70.08%
69.23%
68.76%
70.35%
71.48%
70.14%
66.93%
66.62%
66.39%
Total Expenditure
1,739.97
1,708.13
1,565.67
1,580.87
1,382.57
1,214.50
1,023.20
985.74
891.80
910.37
920.27
Power & Fuel Cost
-
62.14
59.61
56.00
50.61
42.78
36.89
34.75
28.49
26.62
23.12
% Of Sales
-
3.37%
3.58%
3.08%
3.03%
2.78%
2.97%
3.14%
2.94%
2.55%
2.15%
Employee Cost
-
425.68
394.01
361.93
322.58
296.28
274.02
256.51
231.66
220.91
216.67
% Of Sales
-
23.07%
23.67%
19.92%
19.33%
19.23%
22.07%
23.18%
23.92%
21.20%
20.16%
Manufacturing Exp.
-
239.65
214.28
247.42
195.91
184.62
130.32
114.63
107.07
101.94
96.38
% Of Sales
-
12.99%
12.87%
13.61%
11.74%
11.98%
10.50%
10.36%
11.06%
9.78%
8.97%
General & Admin Exp.
-
151.16
152.06
137.54
121.88
106.75
97.57
127.76
110.92
110.04
116.40
% Of Sales
-
8.19%
9.13%
7.57%
7.30%
6.93%
7.86%
11.55%
11.45%
10.56%
10.83%
Selling & Distn. Exp.
-
179.34
189.69
149.45
111.33
83.19
76.02
89.28
62.75
70.53
73.22
% Of Sales
-
9.72%
11.39%
8.22%
6.67%
5.40%
6.12%
8.07%
6.48%
6.77%
6.81%
Miscellaneous Exp.
-
108.42
57.83
69.34
58.95
44.10
54.28
32.38
30.66
32.49
73.22
% Of Sales
-
5.88%
3.47%
3.82%
3.53%
2.86%
4.37%
2.93%
3.17%
3.12%
3.09%
EBITDA
168.67
137.19
99.25
236.42
286.04
326.25
218.33
120.84
76.65
131.57
154.50
EBITDA Margin
8.84%
7.43%
5.96%
13.01%
17.14%
21.17%
17.59%
10.92%
7.91%
12.63%
14.38%
Other Income
5.09
7.96
5.45
18.72
2.63
3.42
9.06
4.80
6.70
8.05
5.93
Interest
126.76
122.25
66.23
39.01
25.27
14.14
22.26
26.25
21.09
23.51
6.21
Depreciation
133.47
126.45
113.84
91.87
70.61
78.96
73.13
70.82
71.57
67.71
63.28
PBT
45.60
-103.55
-75.36
124.27
192.79
236.57
132.00
28.57
-9.31
48.40
90.94
Tax
13.82
-7.81
3.58
38.79
50.54
81.77
38.95
4.45
-6.41
7.24
13.87
Tax Rate
30.31%
7.33%
-4.81%
28.56%
26.22%
34.56%
29.51%
15.58%
68.85%
14.96%
15.25%
PAT
31.78
-95.13
-73.74
98.46
142.25
154.80
93.05
24.12
-2.90
41.16
77.06
PAT before Minority Interest
31.94
-98.68
-77.95
97.00
142.25
154.80
93.05
24.12
-2.90
41.16
77.06
Minority Interest
0.16
3.55
4.21
1.46
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
1.67%
-5.16%
-4.43%
5.42%
8.53%
10.05%
7.49%
2.18%
-0.30%
3.95%
7.17%
PAT Growth
127.56%
-
-
-30.78%
-8.11%
66.36%
285.78%
-
-
-46.59%
 
EPS
3.44
-10.31
-7.99
10.67
15.41
16.77
10.08
2.61
-0.31
4.46
8.35

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Shareholder's Funds
939.28
1,022.00
1,109.90
1,028.25
904.64
768.99
679.57
660.62
674.98
651.34
Share Capital
18.46
18.45
18.44
18.43
18.43
18.43
18.43
18.43
18.43
18.43
Total Reserves
914.40
997.81
1,087.93
1,009.16
886.21
750.56
661.14
642.19
656.55
632.91
Non-Current Liabilities
608.61
603.54
421.90
205.44
156.60
158.36
101.00
116.42
125.34
147.04
Secured Loans
474.52
533.20
351.73
143.50
95.88
96.94
96.93
128.66
123.28
132.31
Unsecured Loans
41.50
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
35.65
35.82
33.68
33.40
31.74
66.35
27.14
15.95
23.77
30.91
Current Liabilities
1,061.86
808.47
645.50
480.79
518.16
406.92
458.99
445.50
417.36
390.39
Trade Payables
308.52
208.13
153.64
123.46
133.29
113.23
165.60
170.72
149.55
164.03
Other Current Liabilities
323.12
192.71
149.80
132.06
139.61
129.48
135.81
117.13
119.66
72.16
Short Term Borrowings
374.03
362.01
260.52
119.45
103.73
117.31
105.98
113.39
109.93
118.36
Short Term Provisions
56.20
45.62
81.53
105.82
141.53
46.91
51.59
44.26
38.22
35.84
Total Liabilities
2,602.58
2,430.39
2,177.90
1,714.48
1,579.40
1,334.27
1,239.56
1,222.54
1,217.68
1,188.77
Net Block
1,193.11
996.88
954.29
678.25
555.10
569.94
589.74
467.65
488.86
439.89
Gross Block
2,231.78
1,927.63
1,780.68
1,422.93
1,236.19
1,177.74
1,126.76
934.65
885.11
769.65
Accumulated Depreciation
1,038.67
930.74
826.39
744.68
681.09
607.80
537.02
467.00
396.25
329.75
Non Current Assets
1,399.91
1,428.57
1,190.06
844.63
712.47
711.75
676.45
684.49
678.73
616.72
Capital Work in Progress
90.01
320.54
124.81
113.60
121.53
68.19
50.70
185.43
135.56
90.63
Non Current Investment
1.46
1.46
1.46
1.46
0.02
0.02
0.02
0.02
0.02
0.02
Long Term Loans & Adv.
101.69
102.75
102.45
49.06
33.69
71.54
34.30
29.83
41.35
72.02
Other Non Current Assets
13.64
6.93
7.04
2.26
2.13
2.05
1.68
1.56
12.94
14.15
Current Assets
1,179.26
1,001.82
987.84
869.85
866.92
622.53
563.10
538.05
538.96
571.98
Current Investments
0.00
0.00
7.24
1.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
405.21
419.35
353.06
325.99
310.52
237.85
208.32
183.45
193.38
186.94
Sundry Debtors
489.17
352.41
406.20
350.94
297.25
233.82
210.14
195.84
209.51
215.68
Cash & Bank
32.99
17.08
24.32
13.34
19.77
14.34
37.93
36.26
11.90
62.59
Other Current Assets
251.89
45.50
42.23
20.18
239.39
136.52
106.71
122.51
124.17
106.78
Short Term Loans & Adv.
205.04
167.48
154.78
158.41
204.80
124.62
97.60
106.96
117.71
89.21
Net Current Assets
117.40
193.35
342.34
389.06
348.77
215.61
104.12
92.55
121.60
181.60
Total Assets
2,579.17
2,430.39
2,177.90
1,714.48
1,579.39
1,334.28
1,239.55
1,222.54
1,217.69
1,188.70

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Cash From Operating Activity
192.23
94.94
155.39
178.83
173.83
82.22
122.85
132.11
122.72
88.64
PBT
-103.55
-75.36
124.27
192.79
236.57
132.00
28.57
-9.31
48.40
90.94
Adjustment
249.98
183.64
137.55
120.88
87.12
109.76
99.51
89.35
97.67
64.60
Changes in Working Capital
54.91
2.79
-88.47
-73.19
-108.79
-139.81
-1.49
55.62
-13.23
-43.25
Cash after chg. in Working capital
201.34
111.07
173.35
240.48
214.91
101.94
126.60
135.66
132.83
112.29
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-6.17
-17.12
-29.49
-61.65
-41.08
-19.72
-3.75
-3.55
-10.12
-23.65
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
-2.94
0.99
11.53
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-101.61
-339.11
-432.52
-208.17
-121.41
-66.69
-55.93
-103.76
-135.43
-170.55
Net Fixed Assets
-45.09
-222.13
-150.58
-161.10
-111.78
-68.48
-57.37
-99.41
-160.40
-163.74
Net Investments
-107.79
7.24
-39.30
-17.44
-0.01
0.00
-0.01
0.17
0.21
15.47
Others
51.27
-124.22
-242.64
-29.63
-9.62
1.79
1.45
-4.52
24.76
-22.28
Cash from Financing Activity
-76.79
241.42
280.43
22.80
-44.37
-29.87
-63.95
-16.14
-38.77
131.57
Net Cash Inflow / Outflow
13.82
-2.75
3.31
-6.54
8.05
-14.34
2.97
12.22
-51.48
49.66
Opening Cash & Equivalents
12.11
14.86
10.92
17.47
9.42
23.76
20.80
8.58
60.06
10.40
Closing Cash & Equivalent
25.93
12.11
14.86
10.92
17.47
9.42
23.76
20.80
8.58
60.06

Financial Ratios

Consolidated /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Book Value (Rs.)
101.06
110.17
120.02
111.51
98.17
83.45
73.75
71.69
73.25
70.68
ROA
-3.92%
-3.38%
4.98%
8.64%
10.63%
7.23%
1.96%
-0.24%
3.42%
7.22%
ROE
-10.13%
-7.34%
9.09%
14.72%
18.50%
12.85%
3.60%
-0.43%
6.21%
12.55%
ROCE
0.79%
-0.43%
11.25%
17.50%
23.03%
15.67%
5.78%
1.23%
7.62%
11.80%
Fixed Asset Turnover
0.89
0.90
1.13
1.25
1.28
1.08
1.07
1.06
1.26
1.55
Receivable days
83.23
83.16
76.04
70.89
62.90
65.26
66.96
76.39
74.23
67.31
Inventory Days
81.55
84.67
68.19
69.62
64.95
65.58
64.61
71.01
66.40
58.84
Payable days
174.05
132.53
90.44
89.88
98.49
143.70
67.82
71.91
66.57
61.79
Cash Conversion Cycle
-9.27
35.30
53.79
50.63
29.37
-12.86
63.74
75.49
74.06
64.37
Total Debt/Equity
1.11
0.96
0.59
0.31
0.27
0.34
0.39
0.45
0.42
0.43
Interest Cover
0.13
-0.12
4.48
8.63
17.73
6.93
2.09
0.56
3.06
15.64

Annual Reports:

FY 2026
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017

News Update:


  • Indoco Remedies - Quarterly Results
    28th Oct 2026, 00:00 AM

    Read More
  • Indoco Remedies gets nod to incorporate wholly owned subsidiary
    19th Sep 2026, 11:49 AM

    The committee of executive directors of the company in its meeting held on September 18, 2026 has considered and approved the same

    Read More
  • USFDA completes inspection at Indoco Remedies’ Goa manufacturing facility
    7th Sep 2026, 11:37 AM

    On conclusion of the inspection, the company received 7 observations in Form 483

    Read More
  • Indoco Remedies executes Deed of Conveyance to sell land in Mumbai
    28th Aug 2026, 14:20 PM

    The total consideration agreed for sale of land is Rs 64 crore

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.